Optimizing clinical trial site performance: A focus on three AI capabilities
IBM Journey to AI blog
AUGUST 7, 2023
2,3 When clinical trials are prematurely discontinued due to trial site underperformance, the research questions remain unanswered and research findings end up not published. It explores the impact of different scenarios, evaluate trade-offs, and determine the optimal actions to be taken. Clinical Trials. 2019;16(2):183-193.
Let's personalize your content